Status:
COMPLETED
Assessment of Hypoxia Before Radioembolization Treatment With 18F-FMISO PET
Lead Sponsor:
Ankara University
Conditions:
Radioembolization
Radiotherapy
Eligibility:
All Genders
18+ years
Brief Summary
Hypoxia is a known factor for resistance to radiotherapy in tumors. Response to transarterial radioembolization is known to be variable between different patients even if the same dose of radiation wa...
Eligibility Criteria
Inclusion
- Diagnosed with colorectal carcinoma with liver metastasis or hepatocellular carcinoma.
- Is not eligible for surgery
- Above 18 years old
- The patients who are referred for transarterial radioembolization treatment to Ankara University School of Medicine Department of Nuclear Medicine.
Exclusion
- Patients with ECOG performance score \>1
- Claustrophobia
- Life expectancy shorter than 3 months
- Pregnant or breast-feeding patients
Key Trial Info
Start Date :
August 15 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 15 2024
Estimated Enrollment :
64 Patients enrolled
Trial Details
Trial ID
NCT06027021
Start Date
August 15 2023
End Date
July 15 2024
Last Update
July 30 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ankara University
Ankara, Turkey (Türkiye), 06590